2,929
Views
12
CrossRef citations to date
0
Altmetric
Review Paper

Proceedings of the Second Annual Deep Brain Stimulation Think Tank: What's in the Pipeline

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , & show all

References

  • Kelly ML, Malone D, Okun MS, et al. Barriers to investigator-initiated deep brain stimulation and device research. Neurology 2014;82(16):1465–73.
  • Rossi PJ, Okun MS, Giordano J. Translational imperatives in deep brain stimulation research: Addressing neuroethical issues of consequences and continuity of clinical care. AJOB-Neurosci 2014;5(1):46–8.
  • Giordano J, Hutchison P, Benedikter R. Regrounding medicine amidst a technological imperative and Post-Modern mindset. Int J Polit Cult Soc 2010;10(10).
  • Giordano J, Schatman ME. Pain medicine from “bench to bedside”: Bridging the disconnect(s) between research and clinical care. J Humanities Sci Healthcare 2011;1(1):22–40.
  • Tykocki T, Nauman P, Koziara H, et al. Microlesion effect as a predictor of the effectiveness of subthalamic deep brain stimulation for Parkinson's disease. Stereotact Funct Neurosurg 2013;91(1):12–7.
  • Mann JM, Foote KD, Garvan CW, et al. Brain penetration effects of microelectrodes and DBS leads in STN or GPi. J Neurol, Neurosurg psych 2009;80(7):794–7. doi: 10.1136/jnnp.2008.159558. PubMed PMID: 19237386; PubMed Central PMCID: PMC3791596.
  • Deuschl G, Schüpbach M, Knudsen K, et al. Stimulation of the subthalamic nucleus at an earlier disease stage of Parkinson's disease: concept and standards of the EARLYSTIM-study. Parkinsonism Relat Disord 2013;19(1):56–61. doi: 10.1016/j.parkreldis.2012.07.004. PubMed PMID: 22841616.
  • McRae C, Cherin E, Yamazaki TG, et al. Effects of perceived treatment on quality of life and medical outcomes in a double-blind placebo surgery trial. Arch Heneral Psychiat 2004;61(4):412–20. doi: 10.1001/archpsyc.61.4.412. PubMed PMID: 15066900.
  • de la Fuente-Fernandez R. Uncovering the hidden placebo effect in deep-brain stimulation for Parkinson's disease. Parkinsonism & related disorders. 2004;10(3):125–7. doi: 10.1016/j.parkreldis.2003.10.003. PubMed PMID: 15036165.
  • Mestre TA, Shah P, Marras C, et al. Another face of placebo: the lessebo effect in Parkinson disease: meta-analyses. Neurology 2014;82(16):1402–9. doi: 10.1212/WNL.0000000000000340. PubMed PMID: 24658930; PubMed Central PMCID: PMC4001195.
  • Mestre TA, Espay AJ, Marras C, et al. Subthalamic nucleus-deep brain stimulation for early motor complications in Parkinson's disease-the EARLYSTIM trial: Early is not always better. Mov Disord 2014;29(14):1751–56. doi: 10.1002/mds.26024. PubMed PMID: 25227325.
  • Ko JH, Feigin A, Mattis PJ, et al. Network modulation following sham surgery in Parkinson's disease. The Journal of clinical investigation. 2014;124(8):3656–66. doi: 10.1172/JCI75073. PubMed PMID: 25036712; PubMed Central PMCID: PMC4109544.
  • Perestelo-Perez L, Rivero-Santana A, Perez-Ramos J, et al. Deep brain stimulation in Parkinson's disease: meta-analysis of randomized controlled trials. J Neurol 2014;261(11):2051–60. Epub 2014/02/04. doi: 10.1007/s00415-014-7254-6. PubMed PMID: 24487826.
  • Selby JV, Beal AC, Frank L. The Patient-Centered Outcomes Research Institute (PCORI) national priorities for research and initial research agenda. Jama 2012;307(15):1583–4. Epub 2012/04/19. doi: 307/15/1583 [pii], 10.1001/jama.2012.500. PubMed PMID: 22511682.
  • Voon V, Krack P, Lang AE, et al. A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease. Brain 2008;131(Pt 10):2720–8. Epub 2008/10/23. doi: awn214 [pii], 10.1093/brain/awn214. PubMed PMID: 18941146; PubMed Central PMCID: PMC2724899.
  • Air EL, Ostrem JL, Sanger TD, et al. Deep brain stimulation in children: experience and technical pearls. Journal of neurosurgery Pediatrics. 2011;8(6):566–74. doi: 10.3171/2011.8.PEDS11153. PubMed PMID: 22132914.
  • Gimeno H, Tustin K, Lumsden D, et al. Evaluation of functional goal outcomes using the Canadian Occupational Performance Measure (COPM) following Deep Brain Stimulation (DBS) in childhood dystonia. Eur J Paediatr Neurol 2014;18(3):308–16. Epub 2014/01/28. doi: S1090-3798(14)00005-1 [pii], 10.1016/j.ejpn.2013.12.010. PubMed PMID: 24461258.
  • Maier F, Lewis CJ, Horstkoetter N, et al. Patients’ expectations of deep brain stimulation, and subjective perceived outcome related to clinical measures in Parkinson's disease: a mixed-method approach. J Neurol Neurosurg Psychiatry. 2013;84(11):1273–81. Epub 2013/05/30. doi: jnnp-2012-303670 [pii], 10.1136/jnnp-2012-303670. PubMed PMID: 23715910.
  • Lambert C, Zrinzo L, Nagy Z, et al. Confirmation of functional zones within the human subthalamic nucleus: patterns of connectivity and sub-parcellation using diffusion weighted imaging. NeuroImage 2012;60(1):83–94. doi: 10.1016/j.neuroimage.2011.11.082. PubMed PMID: 22173294; PubMed Central PMCID: PMCPMC3315017.
  • Haynes WI, Haber SN. The organization of prefrontal-subthalamic inputs in primates provides an anatomical substrate for both functional specificity and integration: implications for Basal Ganglia models and deep brain stimulation. J Neurosci 2013;33(11):4804–14. doi: 10.1523/jneurosci.4674-12.2013. PubMed PMID: 23486951; PubMed Central PMCID: PMCPMC3755746.
  • Nini A, Feingold A, Slovin H, et al. Neurons in the globus pallidus do not show correlated activity in the normal monkey, but phase-locked oscillations appear in the MPTP model of parkinsonism. J Neurophys 1995;74(4):1800–5. PubMed PMID: 8989416.
  • Brown P, Oliviero A, Mazzone P, et al. Dopamine dependency of oscillations between subthalamic nucleus and pallidum in Parkinson's disease. J Neurosci 2001;21(3):1033–8. PubMed PMID: 11157088.
  • Bevan MD, Magill PJ, Terman D, et al. Move to the rhythm: oscillations in the subthalamic nucleus-external globus pallidus network. Trends Neurosci 2002;25(10):525–31. PubMed PMID: 12220881.
  • Levy R, Hutchison WD, Lozano AM, et al. Synchronized neuronal discharge in the basal ganglia of parkinsonian patients is limited to oscillatory activity. J Neurosci. 2002;22(7):2855–61. doi: 20026193. PubMed PMID: 11923450.
  • Schnitzler A, Timmermann L, Gross J. Physiological and pathological oscillatory networks in the human motor system. J Physiol Paris 2006;99(1):3–7. doi: 10.1016/j.jphysparis.2005.06.010. PubMed PMID: 16054347.
  • Uhlhaas PJ, Singer W. Neural synchrony in brain disorders: relevance for cognitive dysfunctions and pathophysiology. Neuron 2006;52(1):155–68. doi: 10.1016/j.neuron.2006.09.020. PubMed PMID: 17015233.
  • Hammond C, Bergman H, Brown P. Pathological synchronization in Parkinson's disease: networks, models and treatments. Trends Neurosci 2007;30(7):357–64. doi: 10.1016/j.tins.2007.05.004. PubMed PMID: 17532060.
  • de Solages C, Hill BC, Koop MM, et al. Bilateral symmetry and coherence of subthalamic nuclei beta band activity in Parkinson's disease. Exper Neurol 2010;221(1):260–6. doi: 10.1016/j.expneurol.2009.11.012. PubMed PMID: 19944098.
  • Kuhn J, Gaebel W, Klosterkoetter J, et al. Deep brain stimulation as a new therapeutic approach in therapy-resistant mental disorders: ethical aspects of investigational treatment. Eur Arch Psychiatry Clin Neurosci 2009;259(Suppl 2):S135–41. Epub 2009/11/13. doi: 10.1007/s00406-009-0055-8. PubMed PMID: 19876671.
  • de Hemptinne C, Ryapolova-Webb ES, Air EL, et al. Exaggerated phase-amplitude coupling in the primary motor cortex in Parkinson disease. Proc Natl Acad Sci USA 2013;110(12):4780–5. doi: 10.1073/pnas.1214546110. PubMed PMID: 23471992; PubMed Central PMCID: PMC3606991.
  • Yang AI, Vanegas N, Lungu C, et al. Beta-coupled high-frequency activity and Beta-locked neuronal spiking in the subthalamic nucleus of Parkinson's disease. J Neurosci 2014;34(38):12816–27. doi: 10.1523/JNEUROSCI.1895-14.2014. PubMed PMID: 25232117; PubMed Central PMCID: PMC4166162.
  • Williams NR, Foote KD, Okun MS. STN vs. GPi Deep Brain Stimulation: Translating the Rematch into Clinical Practice. Mov Disord Clin Pract (Hoboken) 2014;1:24–35.
  • Krack P, Pollak P, Limousin P, et al. Inhibition of levodopa effects by internal pallidal stimulation. Movement Disorders 1998;13(4):648–52.
  • Nestor KA, Jones JD, Butson CR, et al. Coordinate-based lead location does not predict Parkinson's disease deep brain stimulation outcome. PloS one 2014;9(4):e93524. doi: 10.1371/journal.pone.0093524. PubMed PMID: 24691109; PubMed Central PMCID: PMC3972103.
  • Williams NR, Foote KD, Okun MS. STN vs. GPi deep brain stimulation: Translating the rematch into clinical practice. Mov Disord Clin Pract (Hoboken) 2014;1(1):24–35. doi: 10.1002/mdc3.12004. PubMed PMID: 24779023; PubMed Central PMCID: PMC4000041.
  • Rothlind JC, York MK, Carlson K, et al. Neuropsychological changes following deep brain stimulation surgery for Parkinson's disease: comparisons of treatment at pallidal and subthalamic targets versus best medical therapy. J Neurol Neurosurg Psychiatry 2014. doi: 10.1136/jnnp-2014-308119. PubMed PMID: 25185211.
  • Taba HA, Wu SS, Foote KD, et al. A closer look at unilateral versus bilateral deep brain stimulation: results of the National Institutes of Health COMPARE cohort. J Neurosurg 2010;113(6):1224–9. Epub 2010/09/21. doi: 10.3171/2010.8.JNS10312. PubMed PMID: 20849215.
  • Rocchi L, Chiari L, Cappello A, et al. Comparison between subthalamic nucleus and globus pallidus internus stimulation for postural performance in Parkinson's disease. Gait Posture 2004;19(2):172–83. doi: 10.1016/s0966-6362(03)00059-6. PubMed PMID: 15013506.
  • Spieles-Engemann AL, Steece-Collier K, Behbehani MM, et al. Subthalamic nucleus stimulation increases brain derived neurotrophic factor in the nigrostriatal system and primary motor cortex. J Parkinson's Disease 2011;1(1):123–36. PubMed PMID: 22328911; PubMed Central PMCID: PMC3275429.
  • Charles PD, Gill CE, Davis TL, et al. Is deep brain stimulation neuroprotective if applied early in the course of PD? Nat Clin Pract Neuro 2008;4(8):424–6. doi: Doi 10.1038/Ncpneuro0848. PubMed PMID: WOS:000258106000008.
  • Kahn E, D’Haese PF, Dawant B, et al. Deep brain stimulation in early stage Parkinson's disease: operative experience from a prospective randomised clinical trial. J Neurol, Neurosurg, Psych 2012;83(2):164–70. doi: 10.1136/jnnp-2011-300008. PubMed PMID: 21890575; PubMed Central PMCID: PMC3733009.
  • Fasano A, Daniele A, Albanese A. Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation. Lancet Neurol 2012;11(5):429–42. Epub 2012/04/21. doi: S1474-4422(12)70049-2 [pii], 10.1016/S1474-4422(12)70049-2. PubMed PMID: 22516078.
  • Zibetti M, Torre E, Cinquepalmi A, et al. Motor and nonmotor symptom follow-up in parkinsonian patients after deep brain stimulation of the subthalamic nucleus. Eur Neurol 2007;58(4):218–23. doi: 10.1159/000107943. PubMed PMID: 17823535.
  • Troche MS, Brandimore AE, Foote KD, et al. Swallowing and deep brain stimulation in Parkinson's disease: a systematic review. Parkinsonism Relat Disord 2013;19(9):783–8. doi: 10.1016/j.parkreldis.2013.05.001. PubMed PMID: 23726461; PubMed Central PMCID: PMCPMC3775508.
  • Fabbri M, Guedes LC, Coelho M, et al. Subthalamic deep brain stimulation effects on odor identification in Parkinson's disease. Eur J Neurol 2015;22(1):207–10. doi: 10.1111/ene.12396. PubMed PMID: 24602222.
  • Nazzaro JM, Pahwa R, Lyons KE. The impact of bilateral subthalamic stimulation on non-motor symptoms of Parkinson's disease. Parkinsonism Relat Disord 2011;17(8):606–9. doi: 10.1016/j.parkreldis.2011.05.009. PubMed PMID: 21669545.
  • Martinez-Martin P, Chaudhuri KR, Rojo-Abuin JM, et al. Assessing the non-motor symptoms of Parkinson's disease: MDS-UPDRS and NMS Scale. Eur J Neurol 2015;22(1):37–43. doi: 10.1111/ene.12165.
  • Chaudhuri KR, Martinez-Martin P, Schapira AH, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study. Mov Disord 2006;21(7):916–23. Epub 2006/03/21. doi: 10.1002/mds.20844. PubMed PMID: 16547944.
  • Butson CR, Cooper SE, Henderson J, et al. Patient-specific analysis of the volume of tissue activated during deep brain stimulation. NeuroImage 2007;34(2):661–70.
  • Frankemolle AMM, Wu J, Noecker AM, et al. Reversing cognitive–motor impairments in Parkinson's disease patients using a computational modelling approach to deep brain stimulation programming. Brain 2010;133:746–61.
  • Lempka SF, McIntyre CC. Theoretical analysis of the local field potential in deep brain stimulation applications. PloS one 2013;8(3):e59839.
  • Bronte-Stewart H, Barberini C, Koop MM, et al. The STN beta-band profile in Parkinson's disease is stationary and shows prolonged attenuation after deep brain stimulation. Exper Neurol 2009;215:20–8.
  • Kuhn AA, Kempf F, Brucke C, et al. High-frequency stimulation of the subthalamic nucleus suppresses oscillatory activity in patients with Parkinson's disease in parallel with improvement in Motor performance. J Neuros 2008;28(24):6165–73.
  • Whitmer D, de Solages C, Hill BC, et al. High frequency deep brain stimulation attenuates subthalamic and cortical rhythms in Parkinson's disease. Frontiers Human Neurosci 2012;6:155.
  • Miller KJ, Hermes D, HIne CJ, et al. Human motor cortical activity is selectively phase-entrained on underlying rhythms. PLoS Comput Biol 2012;8(9):e1002655.
  • López-Azcárate J, Tainta M, Rodríguez-Oroz MC, et al. Coupling between beta and high-frequency activity in the human subthalamic nucleus may be a pathophysiological mechanism in Parkinson's disease. J Neurosci 2010;30(19):6667–77. doi: 10.1523/jneurosci.5459-09.2010. PubMed PMID: 20463229.
  • Walker HC, Huang H, Gonzalez CL, et al. Short latency activation of cortex during clinically effective subthalamic deep brain stimulation for Parkinson's disease. Mov Disord 2012;27(7):864–73. doi: 10.1002/mds.25025. PubMed PMID: 22648508; PubMed Central PMCID: PMC3636546.
  • Walker HC, Huang H, Gonzalez CL, et al. Short latency activation of cortex by clinically effective thalamic brain stimulation for tremor. Mov Disord 2012;27(11):1404–12. doi: 10.1002/mds.25137. PubMed PMID: 22926754; PubMed Central PMCID: PMC3691999.
  • Rosin B, Slovik M, Mitelman R, et al. Closed-loop deep brain stimulation is superior in ameliorating parkinsonism. Neuron 2011;72(2):370–84. doi: 10.1016/j.neuron.2011.08.023. PubMed PMID: 22017994.
  • Okun MS, Foote KD, Wu SS, et al. A trial of scheduled deep brain stimulation for tourette syndrome: Moving away from continuous deep brain stimulation paradigms. Arch Neurol 2012:1–10. Epub 2012/10/10. doi: 10.1001/jamaneurol.2013.580. PubMed PMID: 23044532.
  • Maling N, Hashemiyoon R, Foote KD, et al. Increased thalamic gamma band activity correlates with symptom relief following deep brain stimulation in humans with Tourette's syndrome. PloS One 2012;7(9):e44215. Epub 2012/09/13. doi: 10.1371/journal.pone.0044215. PubMed PMID: 22970181; PubMed Central PMCID: PMC3435399.
  • Afshar P, Khambhati A, Stanslaski S, et al. A translational platform for prototyping closed-loop neuromodulation systems. Frontiers Neural Circuits 2013;6:117.
  • Sun FT, Morrell MJ, Wharen RE. Responsive cortical stimulation for the treatment of epilepsy. Neurotherapeutics 2008;5:68–74.
  • Pouratian N, Zheng Z, Bari AA, et al. Multi-institutional evaluation of deep brain stimulation targeting using probabilistic connectivity-based thalamic segmentation. J Neurosur 2011;115(5):995–1004. doi: 10.3171/2011.7.JNS11250. PubMed PMID: 21854118.
  • Elias WJ, Zheng ZA, Domer P, et al. Validation of connectivity-based thalamic segmentation with direct electrophysiologic recordings from human sensory thalamus. NeuroImage 2012;59(3):2025–34. doi: 10.1016/j.neuroimage.2011.10.049. PubMed PMID: 22036683.
  • Kim JP, Min HK, Knight EJ, et al. Centromedian-parafascicular deep brain stimulation induces differential functional inhibition of the motor, associative, and limbic circuits in large animals. Biol Psychiatry 2013;74(12):917–26. doi: 10.1016/j.biopsych.2013.06.024. PubMed PMID: 23993641; PubMed Central PMCID: PMC3910443.
  • Knight EJ, Min HK, Hwang SC, et al. Insular and prefrontal cortical activation during nucleus accumbens high frequency stimulation in a large animal model: A functional MRI atudy. PloS One 2013;8(2):e56640.
  • Paek SB, Min HK, Kim IY, et al. Frequency-dependent functional neuromodulatory effects on the motor network by ventral lateral thalamic deep brain stimulation in swine. NeuroImage 2015;105:181–8.
  • Min HK, Hwang SC, Marsh MP, et al. Deep brain stimulation induces BOLD activation in motor and non-motor networks: an fMRI comparison study of STN and EN/GPi DBS in large animals. NeuroImage 2012;63(3):1408–20. doi: 10.1016/j.neuroimage.2012.08.006. PubMed PMID: 22967832; PubMed Central PMCID: PMC3487590.
  • Min HK, Ross EK, Lee KH, et al. Subthalamic nucleus deep brain stimulation induces Motor network BOLD activation: Use of a high precision MRI guided stereotactic system for nonhuman primates. Brain Stimulat 2014;7(4):603–7. doi: Doi 10.1016/J.Brs.2014.04.007. PubMed PMID: WOS:000339984300015.
  • Gorny KR, Presti MF, Goerss SJ, et al. Measurements of RF heating during 3.0-T MRI of a pig implanted with deep brain stimulator. Magn Reson Imaging 2013;31(5):783–8. doi: Doi 10.1016/J.Mri.2012.11.005. PubMed PMID: WOS:000319103000021.
  • Lee KH, Chang S-Y, Roberts DW, et al. Neurotransmitter release from high-frequency stimulation of the subthalamic nucleus. J Neurosurg 2004;101:511–7.
  • Shon Y-M, Chang S-Y, Tye SJ, et al. Comonitoring of adenosine and dopamine using the wireless instantaneous neurotransmitter concentration system: Proof of principle. J Neurosurg 2010;112:539–48.
  • Shon Y-M, Lee KH, Goerss SJ, et al. High frequency stimulation of the subthalamic nucleus evokes striatal dopamine release in a large animal model of human DBS neurosurgery. Neurosci Lett 2010;475:136–40.
  • Grahn PJ, Mallory GW, Khurram OU, et al. A neurochemical closed-loop controller for deep brain stimulation: toward individualized smart neuromodulation therapies. Frontiers Neurosci 2014;8:169. doi: 10.3389/fnins.2014.00169. PubMed PMID: 25009455; PubMed Central PMCID: PMC4070176.
  • Marceglia S, Mrakic-Sposta S, Tommasi G, et al. Multicenter study report: electrophysiological monitoring procedures for subthalamic deep brain stimulation surgery in Parkinson's disease. Neurol Sci: Off J Italian Neurol Soc Italian Soc Clin Neurophys 2010;31(4):449–57. Epub 2010/04/24. doi: 10.1007/s10072-010-0254-0. PubMed PMID: 20414706.
  • Contarino MF, Bour LJ, de Bie RMA, et al. Steering deep brain stimulation: An exploratory study with a new 32-contact lead. Mov Disord 2013;28:S439–S40. PubMed PMID: WOS:000320940505143.
  • Bour LJ, Verhagen R, Contarino F, et al. A new DBS lead: Simultaneous 32-contact local field potential recording in the Parkinsonian STN. Mov Disord 2013;28:S445–S. PubMed PMID: WOS:000320940505155.
  • Brocker DT, Swan BD, Turner DA, et al. Improved efficacy of temporally non-regular deep brain stimulation in Parkinson's disease. Exp Neurol 2013;239:60–7. doi: 10.1016/j.expneurol.2012.09.008. PubMed PMID: 23022917; PubMed Central PMCID: PMC3547657.
  • Tass PA, Qin L, Hauptmann C, et al. Coordinated reset has sustained aftereffects in Parkinsonian monkeys. Ann Neurol 2012;72(5):816–20. doi: 10.1002/ana.23663. PubMed PMID: 23280797.